PITTSBURGH, July 25, 2024 /PRNewswire/ -- PANTHERx
Rare, one of the nation's largest and fastest growing rare disease
specialty pharmacies, today announced the appointment of Bansi
Nagji as CEO effective August 1,
2024. In this role, Mr. Nagji will continue his existing
service as a member of the Company's board of directors.
Rob Snyder, the Company's current
co-founder and CEO, will become full-time Executive Chair of
PANTHERx Rare, also effective August
1.
Mr. Nagji brings to the CEO role more than 25 years of
leadership experience spanning pharma services and supply chain,
healthcare technology, and digital platforms. He has deep operating
and strategic experience leading high-growth businesses and
developing and executing organic and inorganic growth strategies.
Mr. Nagji has served as Executive Chair at PANTHERx Rare since
December 2023. Previously, he served
as President, Healthcare at GoodRx, Inc., in addition to Executive
Vice President and Chief Strategy and Business Development Officer
at McKesson Corporation. Mr. Nagji also has extensive background as
a board member for both private and public companies, including
Change Healthcare, Deloitte, and Parata Systems.
Since co-founding PANTHERx Rare in 2011, Dr. Snyder has helped
lead the organization through a sustained period of growth and
transformation. As CEO, he was responsible for a variety of
clinical, operational, and business development initiatives that
continue to deliver value to PANTHERx Rare. In his role as
Executive Chair, he will be responsible for working with industry
partners to ensure PANTHERx Rare maintains its industry-leading
reputation for delivering quality patient access to essential
medications.
Mr. Nagji said, "PANTHERx Rare has achieved significant scale
and impact under Rob's leadership since 2011, and I am thrilled to
move into the role of CEO to lead the Company through its next
phase of growth. Throughout my career in healthcare, I have focused
on building businesses that help people gain critical access to the
medications they need, and I am energized to leverage this
experience to support PANTHERx Rare's long-term growth strategy and
build additional scale to advance our important mission of helping
people who are living with challenging rare diseases. I have
tremendous respect for the people of PANTHERx Rare who created a
culture that always puts patients first, and I look forward to
continued collaboration with Rob in his new role as Executive
Chair."
Dr. Snyder added, "Since founding PANTHERx Rare, our goal has
been to improve every aspect of the patient experience. It has been
incredibly rewarding to lead the organization through a significant
period in its evolution, and I am excited to commit my full-time
focus to further develop the access and support service innovations
we deliver to our patients along their health journey. As PANTHERx
Rare continues its next phase of growth, I am excited to see Bansi
steer the organization through this important transformation.
Having worked closely with Bansi for much of the past year, I am
confident he brings the right combination of skills and experience
to lead the company, and I'm energized to continue working with
him."
These executive appointments complement the company's existing
deep leadership bench and rapidly growing team of professionals
dedicated to expert and empathetic patient care.
About PANTHERx Rare
PANTHERx Rare is a specialty pharmacy purely focused on
rare and orphan diseases, distributing several orphan products and
providing access and support services to those needing them most.
Known as The Rare Disease Pharmacy®, PANTHERx transforms lives by
delivering medicine breakthroughs, clinical excellence, and access
solutions to people living with rare and devastating
conditions.
PANTHERx is a dual-accredited specialty pharmacy, holding
distinctions in rare disease including the Accreditation Commission
for Health Care (ACHC) Distinction in Orphan Drugs and Utilization
Review Accreditation Commission (URAC) Rare Disease Center of
Excellence. As a pharmacy focused on patient satisfaction, PANTHERx
is the seven-time winner of the prestigious MMIT Patient Choice
Award, including the 2024 honor. PANTHERx is headquartered
in Pittsburgh, Pennsylvania and is licensed in all 50 states and US
territories.
For more information, please
contact marketing@pantherxrare.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pantherx-rare-appoints-bansi-nagji-as-ceo-rob-snyder-appointed-executive-chair-302205045.html
SOURCE PANTHERx Rare Pharmacy